期刊文献+

复合通用CD4^+T辅助细胞表位基因克隆载体的构建及测序 被引量:2

Construction and Sequencing of Cloning Vector for Recombinant Universal CD4^+ T Helper Multi-epitope Gene
下载PDF
导出
摘要 目的构建复合通用CD4+T辅助细胞表位基因克隆载体,并进行测序。方法由DNA work2.0软件设计并人工合成20条55个碱基的寡核苷酸序列,利用套叠PCR技术人工合成全基因序列,并克隆至pUC19载体,转化大肠杆菌DH5α,提取质粒,酶切鉴定并进行测序。结果经PCR扩增出645bp的目的DNA片段。酶切鉴定筛选出8个阳性克隆,经测序获得一个序列完全正确的克隆。结论已成功构建了复合通用CD4+T辅助细胞表位基因克隆载体,为研究表位疫苗和细菌多糖结合疫苗提供了新的载体表位。 Objective To construct and sequence the cloning vector for recombinant universal CD4 ^+ T helper multi-epitope gene. bieth- ods Design and synthesize 20 oligonucleotide fragments,each at a length of 55 bp,by DNA work 2.0 software.Synthesize the full-length of gene by overlap PCR and clone into vector pUC19. Transform the recombinant plasmid to E. coli DH5a,then extract the plasmids,identify by restriction analysis and screen by sequencing.Remits A DNA fragment at length of 645 bp was amplified by PCR. Eight positive clones were screened by restriction analysis, of which one clone with completely correct sequence was obtained. Conclusion The cloning vector for recombinant universal CD4^+ T helper multi-epitope gene was successfully constructed, which provided new carrier epitopes for the development of epitope vaccine and bacterial polysaecharide conjugate vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第5期353-355,359,共4页 Chinese Journal of Biologicals
关键词 通用CD4^+T辅助细胞表位 克隆载体 构建 测序 Universal CD4 ^+ T helper muhi-epitope Cloning vector Construction Sequencing
  • 相关文献

参考文献9

  • 1Agadjanyan MG,Ghochikyan A,Petrushina I,et al.Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.J Immunol,2005,174(3):1580-1586.
  • 2Baraldo K,Mori E,Bartoloni A,et al.N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines.Infect Immun,2004,72:4884-4887.
  • 3Subramonia P.Synthetic peptides representing a T-cell epitope as a carrier molecule for conjugate vaccines.United States Patent.Patent number:5,785,973; Date of patent:Jul.28,1998.
  • 4Diethelm-Okita BM,Okita DK,Banaszak L,et al.Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins.J Infect Dis,2000,181(3):1001-1009.
  • 5J Alexander,Fikes J,Hoffman S,et al.The optimization of helper T lymphocyte (HTL) function in vaccine development.Immunol Res,1998,18(2):79-92.
  • 6Harding CV.Unanue ER.Cellular mechanisms of antigen processing and the function of class Ⅰ and Ⅱ major histocompatibility complex molecules.Cell Regul,1990,1(7):499-509.
  • 7Falugi F,Petracca R,Mariani M,et al.Rationally designed strings of promiscuous CD4(+)T cell epitopes provide help to Haemophilus in fluenzae type b oligosaccharide:a model for new conjugate vaccines.Fur J Immunol,2001,31(12):3816-3824.
  • 8Alxander J,Del Guercio MF,Maewal A,et al.Clinical Immunology:Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates in duce specific high titer IgG antibody responses.J Immunol,2000,164:1625-1633.
  • 9Hoover DM,Lubkowski J.DNA Works:an automated method for designing oligonucleotides for PCR-based gene synthesis.Nucleic Acids Res,2002,30(10):e43.

同被引文献22

  • 1于瑞嵩,黄建珍,李震.尿素浓度梯度复性重组牛白细胞介素-2[J].上海农业学报,2006,22(4):33-36. 被引量:4
  • 2Barrios C, Lussow AR,Van Embden J,et al. Mycobacterial heat-shock proteins as carrier molecules. Ⅱ: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guerin priming. Eur J Immunol, 1992, 22(6): 1365-1372.
  • 3Amir-Kroll V, Nussbaum G, Cohen IR. Proteins and their derived peptides as carriers in a conjugate vaccine for streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid. J Immunol, 2003, 170 (12): 6165 - 6171.
  • 4Alexander J, Del Guercio MF, Maewal A, et al. Clinical immunology: linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses. J Immunol, 2000, 164(3): 1625-1633.
  • 5Baraldo K, Mori E, Bartoloni A, et al. N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate Vaccines. Infect Immun, 2004, 72(8): 4884-4887.
  • 6Falugi F, Petracca R, Mariani M, et al. Ratiortally designed strings of promiscuous CD4 ^+ T cell epitopes provide help to Haemophilus infuenzae type b oligosaccharide: a model for new conjugate vaccines. Eur J Immunol, 2001, 31( 12): 3816-3824.
  • 7Dagan R, Eskola J, Leclerc C, et al. Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to Infants. Infect Immun, 1998, 66(5 ): 2093-2098.
  • 8Dagan, R, Goldblatt D, Maleckar JR, et al. Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components. Infect. Immun, 2004, 72(9): 5383-5391.
  • 9Fattom A, Cho YH, Chu C, et al. Epitopic overload at the site of injection may result in suppression of the immune response to combined capsular polysaccharide conjugate vaccines. Vaccine, 1999, 17(2): 126-133.
  • 10Robbins JB, Schneerson R, Anderson P, et al. The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide- based vaccines. JAMA, 1996, 276 ( 14 ): 1181 - 1185.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部